Skip to the page

Data / Form D filings / AdherePlus, Inc.

AdherePlus, Inc.: Form D filing

AdherePlus, Inc., a health care company in Washington, DC, filed a Form D with the SEC in 2026. The latest, on March 3, 2026, reports $50,000 sold of a $15 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6218 GEORGIA AVENUE NO. 5080, Washington, DC, 20011
Phone
(202) 329-1825
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2113859

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 3, 2026New notice$15,000,000$50,000$14,950,0001Feb 15, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
James BreidensteinExecutive Officer, Director
Dan CohenExecutive Officer, Director
Peter PittsDirector
Scott Sigman MDDirector
John StinemanDirector

Every Form D from the week of Mar 2, 2026 · All recent filings in District of Columbia · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what AdherePlus, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.